HAEMONETICS CORPORATION (HAE) Shareholders’ equity 2017–2026
HAEMONETICS CORPORATION (HAE) shareholders’ equity at each fiscal year-end, per SEC filings.
$796.3MFY2026 · since FY2017: $739.6M → $796.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $796.3M | -3.0% |
| FY2025 | $820.8M | -14.5% |
| FY2024 | $960.0M | +17.4% |
| FY2023 | $818.0M | +9.2% |
| FY2022 | $749.4M | +2.4% |
| FY2021 | $731.7M | +24.6% |
| FY2020 | $587.1M | -12.1% |
| FY2019 | $667.9M | -11.2% |
| FY2018 | $752.4M | +1.7% |
| FY2017 | $739.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice